EconPapers    
Economics at your fingertips  
 

Economic Evaluation of Pharmacy Services

Zaheer-Ud-Din Babar
Additional contact information
Zaheer-Ud-Din Babar: School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand and Founding editor, Journal of Pharmaceutical Policy and Practice

in Elsevier Monographs from Elsevier, currently edited by Candice Janco

Abstract: Economic Evaluation of Pharmacy Services provides the latest on the trend to a more product-centered and service-centered practice, eschewing traditional economic evaluation techniques that focus on product-to-product comparisons in favor of evaluating processes that measure costs and health outcomes. Complete with examples focusing on best practices, including various study designs, types of pharmacy services, and types of outcomes being evaluated, the book emphasizes case studies and examples that help readers understand economic evaluation techniques. Many of these techniques are transferable across countries, especially where there are advanced and stable health systems in place. With the help of this practical guide, readers will gain a thorough understanding of the application of economic evaluation of pharmacy services. Delivers a practical guide for conducting economic evaluations of hospital and community pharmacy services Documents the literature around health economic evaluation and innovative pharmacy services Guides the development of a standardized health economic evaluation tool to evaluate these services

Keywords: A proposal; Africa; Anti-coagulation; Application to pharmacy services; Asia; Community; Community pharmacy; Community pharmacy setting; Copolymers; Cost effectiveness model; Cost-effectiveness; Cost-effectiveness analysis; Cost-minimization; Cost-minimization analysis; Cost-benefit analysis; Cost-utility analysis; Cross-linking; Curing; Decision problem; Design issues; Design principles; Developing countries; Economic evaluation; Economic evaluation steps; Europe; Exemplar model; Fluorocarbon elastomers; Fluoroelastomers; Health-related quality of life; Healthcare products and programs; Hospital pharmacy; Incremental analysis; Incremental cost-effectiveness ratio; Institutional setting; Intervention; Latin America; Low- and middle-income countries; Medicines management; Methodological issues; Middle East; Monomers; Needle exchange service; New Zealand; Opportunity cost; Perfluoroelastomers; Pharmacies; Pharmacist; Pharmacists; Pharmacoeconomics; Pharmacy; Pharmacy services; Pilot program; Portugal; Recent developments; Review; South America; Warfarin therapy (search for similar items in EconPapers)
Date: 2016 Originally published 2016-10-14.
Edition: 1
ISBN: 978-0-12-803659-4
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/book/9780128036594
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:monogr:9780128036594

Access Statistics for this book

More books in Elsevier Monographs from Elsevier
Bibliographic data for series maintained by ().

 
Page updated 2025-03-19
Handle: RePEc:eee:monogr:9780128036594